Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-11-26

AUTHORS

Shigehiro Karashima, Takashi Yoneda, Mitsuhiro Kometani, Masashi Ohe, Shunsuke Mori, Toshitaka Sawamura, Kenji Furukawa, Takashi Seta, Masakazu Yamagishi, Yoshiyu Takeda

ABSTRACT

The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25–100 mg daily, n=27) or SPL (12.5–100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated. More... »

PAGES

133-137

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/hr.2015.129

DOI

http://dx.doi.org/10.1038/hr.2015.129

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008996134

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26606875


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eplerenone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperaldosteronism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mineralocorticoid Receptor Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spironolactone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karashima", 
        "givenName": "Shigehiro", 
        "id": "sg:person.01014464376.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014464376.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoneda", 
        "givenName": "Takashi", 
        "id": "sg:person.01327041750.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327041750.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kometani", 
        "givenName": "Mitsuhiro", 
        "id": "sg:person.01177026176.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177026176.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohe", 
        "givenName": "Masashi", 
        "id": "sg:person.01161622470.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161622470.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mori", 
        "givenName": "Shunsuke", 
        "id": "sg:person.0634436105.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634436105.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sawamura", 
        "givenName": "Toshitaka", 
        "id": "sg:person.01245141376.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245141376.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furukawa", 
        "givenName": "Kenji", 
        "id": "sg:person.01005476637.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005476637.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416609.c", 
          "name": [
            "Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seta", 
        "givenName": "Takashi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamagishi", 
        "givenName": "Masakazu", 
        "id": "sg:person.01111610241.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111610241.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeda", 
        "givenName": "Yoshiyu", 
        "id": "sg:person.011107121707.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011107121707.93"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/hr.2012.182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007825260", 
          "https://doi.org/10.1038/hr.2012.182"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2010.166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033022843", 
          "https://doi.org/10.1038/hr.2010.166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.30", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042802941", 
          "https://doi.org/10.1038/hr.2013.30"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2011.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020745088", 
          "https://doi.org/10.1038/hr.2011.35"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03347840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039211825", 
          "https://doi.org/10.1007/bf03347840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2010.221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020353836", 
          "https://doi.org/10.1038/hr.2010.221"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-11-26", 
    "datePublishedReg": "2015-11-26", 
    "description": "The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25\u2013100 mg daily, n=27) or SPL (12.5\u2013100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/hr.2015.129", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1313717", 
        "issn": [
          "0916-9636", 
          "1348-4214"
        ], 
        "name": "Hypertension Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "keywords": [
      "homeostasis model assessment-insulin resistance", 
      "urinary albumin excretion", 
      "plasma renin activity", 
      "primary aldosteronism", 
      "blood pressure", 
      "mineralocorticoid receptor", 
      "adipose tissue", 
      "model assessment-insulin resistance", 
      "treatment of PA", 
      "assessment-insulin resistance", 
      "serum potassium levels", 
      "body mass index", 
      "subcutaneous adipose tissue", 
      "MR blockade", 
      "albumin excretion", 
      "renin activity", 
      "renal effects", 
      "serum creatinine", 
      "aldosterone concentration", 
      "serum lipids", 
      "metabolic syndrome", 
      "mass index", 
      "metabolic factors", 
      "eplerenone", 
      "spironolactone", 
      "potassium levels", 
      "aldosteronism", 
      "patients", 
      "similar degree", 
      "treatment", 
      "MRA", 
      "tissue", 
      "creatinine", 
      "lipids", 
      "syndrome", 
      "blockade", 
      "Visceral", 
      "kidney", 
      "excretion", 
      "months", 
      "CT", 
      "receptors", 
      "effect", 
      "group", 
      "index", 
      "factors", 
      "levels", 
      "activity", 
      "VAT", 
      "study", 
      "analysis software", 
      "potassium", 
      "resistance", 
      "pressure", 
      "concentration", 
      "degree", 
      "PAC", 
      "comparison", 
      "results", 
      "software"
    ], 
    "name": "Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism", 
    "pagination": "133-137", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008996134"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/hr.2015.129"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26606875"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/hr.2015.129", 
      "https://app.dimensions.ai/details/publication/pub.1008996134"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_665.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/hr.2015.129"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      104 URIs      90 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/hr.2015.129 schema:about N054777fbb9a34d8abb2ef5929bc2ab44
2 N0969646b8b2e427292bd86cc914bb200
3 N4a920531fde64d62a0d622e29cb2091c
4 N57d0f6412e674f308067649e18d0c2a8
5 N5c0cc2317790402e9907520416f6ea92
6 N62da1f046ba949a5aa115c418ec50fbc
7 Na851831662f140deb53759394756b453
8 Nb0be1de3bf064af3a360f33ea8fbd980
9 Nb18a6d9d121d4921aa8f292775a21ca2
10 Nb1e0238e2d914215bbafe12eefcef931
11 Nc4a166f056a34b66b2b0911683529d56
12 Ne7ca360575e94eed994aa9b531c03910
13 Nec439d49e10c463e89f1684731d07223
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author Nd94553a7d61740a6aee6339ce43d9263
17 schema:citation sg:pub.10.1007/bf03347840
18 sg:pub.10.1038/hr.2010.166
19 sg:pub.10.1038/hr.2010.221
20 sg:pub.10.1038/hr.2011.35
21 sg:pub.10.1038/hr.2012.182
22 sg:pub.10.1038/hr.2013.30
23 schema:datePublished 2015-11-26
24 schema:datePublishedReg 2015-11-26
25 schema:description The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25–100 mg daily, n=27) or SPL (12.5–100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N790a1a66c86148dab74028f85c8d6d27
29 Nc3b65aecc2744ab9a67025b8ff00e0d6
30 sg:journal.1313717
31 schema:keywords CT
32 MR blockade
33 MRA
34 PAC
35 VAT
36 Visceral
37 activity
38 adipose tissue
39 albumin excretion
40 aldosterone concentration
41 aldosteronism
42 analysis software
43 assessment-insulin resistance
44 blockade
45 blood pressure
46 body mass index
47 comparison
48 concentration
49 creatinine
50 degree
51 effect
52 eplerenone
53 excretion
54 factors
55 group
56 homeostasis model assessment-insulin resistance
57 index
58 kidney
59 levels
60 lipids
61 mass index
62 metabolic factors
63 metabolic syndrome
64 mineralocorticoid receptor
65 model assessment-insulin resistance
66 months
67 patients
68 plasma renin activity
69 potassium
70 potassium levels
71 pressure
72 primary aldosteronism
73 receptors
74 renal effects
75 renin activity
76 resistance
77 results
78 serum creatinine
79 serum lipids
80 serum potassium levels
81 similar degree
82 software
83 spironolactone
84 study
85 subcutaneous adipose tissue
86 syndrome
87 tissue
88 treatment
89 treatment of PA
90 urinary albumin excretion
91 schema:name Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
92 schema:pagination 133-137
93 schema:productId N5156d397294d4c2fbdc5d3b8048cb103
94 N82a79596fb264a9d9b11c33d27aa2c64
95 Ne57a7aa94e2e42409adaeed3ea8c6d6f
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008996134
97 https://doi.org/10.1038/hr.2015.129
98 schema:sdDatePublished 2022-12-01T06:33
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N1c7a4ba7ae474f52b62c835f02ad1c49
101 schema:url https://doi.org/10.1038/hr.2015.129
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N054777fbb9a34d8abb2ef5929bc2ab44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Mineralocorticoid Receptor Antagonists
107 rdf:type schema:DefinedTerm
108 N0969646b8b2e427292bd86cc914bb200 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Spironolactone
110 rdf:type schema:DefinedTerm
111 N1c7a4ba7ae474f52b62c835f02ad1c49 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N216ef20d905d446ea05456e1455d29c1 rdf:first sg:person.01327041750.74
114 rdf:rest Nd7286c229af743e3b53ad8709378eb8c
115 N30bb8965b7914f1ba212cc0d2f3697bb rdf:first sg:person.01161622470.54
116 rdf:rest N42177c5610dc4b2d93e000c64b90a509
117 N42177c5610dc4b2d93e000c64b90a509 rdf:first sg:person.0634436105.20
118 rdf:rest Nd0254b12bbb348e0868383a368872431
119 N4a920531fde64d62a0d622e29cb2091c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Potassium
121 rdf:type schema:DefinedTerm
122 N5156d397294d4c2fbdc5d3b8048cb103 schema:name dimensions_id
123 schema:value pub.1008996134
124 rdf:type schema:PropertyValue
125 N54c7b0f8b94b40dab0ad0d860badbafa rdf:first sg:person.01111610241.58
126 rdf:rest N55d1a4c31a374736b21b30930a289e71
127 N556ecbde079840728402942d4534cf30 rdf:first N63807c655d534d00bfe54b092e1a07e5
128 rdf:rest N54c7b0f8b94b40dab0ad0d860badbafa
129 N55d1a4c31a374736b21b30930a289e71 rdf:first sg:person.011107121707.93
130 rdf:rest rdf:nil
131 N57d0f6412e674f308067649e18d0c2a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Blood Pressure
133 rdf:type schema:DefinedTerm
134 N5c0cc2317790402e9907520416f6ea92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Adult
136 rdf:type schema:DefinedTerm
137 N62da1f046ba949a5aa115c418ec50fbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Aged
139 rdf:type schema:DefinedTerm
140 N63807c655d534d00bfe54b092e1a07e5 schema:affiliation grid-institutes:grid.416609.c
141 schema:familyName Seta
142 schema:givenName Takashi
143 rdf:type schema:Person
144 N790a1a66c86148dab74028f85c8d6d27 schema:issueNumber 3
145 rdf:type schema:PublicationIssue
146 N82a79596fb264a9d9b11c33d27aa2c64 schema:name pubmed_id
147 schema:value 26606875
148 rdf:type schema:PropertyValue
149 Na851831662f140deb53759394756b453 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Kidney Function Tests
151 rdf:type schema:DefinedTerm
152 Naaf4b4ca9fab4e29831eb9f92a7be622 rdf:first sg:person.01005476637.29
153 rdf:rest N556ecbde079840728402942d4534cf30
154 Nb0be1de3bf064af3a360f33ea8fbd980 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Female
156 rdf:type schema:DefinedTerm
157 Nb18a6d9d121d4921aa8f292775a21ca2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Humans
159 rdf:type schema:DefinedTerm
160 Nb1e0238e2d914215bbafe12eefcef931 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Middle Aged
162 rdf:type schema:DefinedTerm
163 Nc3b65aecc2744ab9a67025b8ff00e0d6 schema:volumeNumber 39
164 rdf:type schema:PublicationVolume
165 Nc4a166f056a34b66b2b0911683529d56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Male
167 rdf:type schema:DefinedTerm
168 Nd0254b12bbb348e0868383a368872431 rdf:first sg:person.01245141376.12
169 rdf:rest Naaf4b4ca9fab4e29831eb9f92a7be622
170 Nd7286c229af743e3b53ad8709378eb8c rdf:first sg:person.01177026176.61
171 rdf:rest N30bb8965b7914f1ba212cc0d2f3697bb
172 Nd94553a7d61740a6aee6339ce43d9263 rdf:first sg:person.01014464376.79
173 rdf:rest N216ef20d905d446ea05456e1455d29c1
174 Ne57a7aa94e2e42409adaeed3ea8c6d6f schema:name doi
175 schema:value 10.1038/hr.2015.129
176 rdf:type schema:PropertyValue
177 Ne7ca360575e94eed994aa9b531c03910 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Hyperaldosteronism
179 rdf:type schema:DefinedTerm
180 Nec439d49e10c463e89f1684731d07223 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Eplerenone
182 rdf:type schema:DefinedTerm
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1313717 schema:issn 0916-9636
190 1348-4214
191 schema:name Hypertension Research
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01005476637.29 schema:affiliation grid-institutes:None
195 schema:familyName Furukawa
196 schema:givenName Kenji
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005476637.29
198 rdf:type schema:Person
199 sg:person.01014464376.79 schema:affiliation grid-institutes:grid.9707.9
200 schema:familyName Karashima
201 schema:givenName Shigehiro
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014464376.79
203 rdf:type schema:Person
204 sg:person.011107121707.93 schema:affiliation grid-institutes:grid.9707.9
205 schema:familyName Takeda
206 schema:givenName Yoshiyu
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011107121707.93
208 rdf:type schema:Person
209 sg:person.01111610241.58 schema:affiliation grid-institutes:grid.9707.9
210 schema:familyName Yamagishi
211 schema:givenName Masakazu
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111610241.58
213 rdf:type schema:Person
214 sg:person.01161622470.54 schema:affiliation grid-institutes:grid.9707.9
215 schema:familyName Ohe
216 schema:givenName Masashi
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161622470.54
218 rdf:type schema:Person
219 sg:person.01177026176.61 schema:affiliation grid-institutes:grid.9707.9
220 schema:familyName Kometani
221 schema:givenName Mitsuhiro
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177026176.61
223 rdf:type schema:Person
224 sg:person.01245141376.12 schema:affiliation grid-institutes:grid.9707.9
225 schema:familyName Sawamura
226 schema:givenName Toshitaka
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245141376.12
228 rdf:type schema:Person
229 sg:person.01327041750.74 schema:affiliation grid-institutes:grid.9707.9
230 schema:familyName Yoneda
231 schema:givenName Takashi
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327041750.74
233 rdf:type schema:Person
234 sg:person.0634436105.20 schema:affiliation grid-institutes:grid.9707.9
235 schema:familyName Mori
236 schema:givenName Shunsuke
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634436105.20
238 rdf:type schema:Person
239 sg:pub.10.1007/bf03347840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039211825
240 https://doi.org/10.1007/bf03347840
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/hr.2010.166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033022843
243 https://doi.org/10.1038/hr.2010.166
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/hr.2010.221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020353836
246 https://doi.org/10.1038/hr.2010.221
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/hr.2011.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020745088
249 https://doi.org/10.1038/hr.2011.35
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/hr.2012.182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007825260
252 https://doi.org/10.1038/hr.2012.182
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/hr.2013.30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042802941
255 https://doi.org/10.1038/hr.2013.30
256 rdf:type schema:CreativeWork
257 grid-institutes:None schema:alternateName Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan
258 schema:name Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan
259 rdf:type schema:Organization
260 grid-institutes:grid.416609.c schema:alternateName Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan
261 schema:name Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan
262 rdf:type schema:Organization
263 grid-institutes:grid.9707.9 schema:alternateName Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
264 Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
265 schema:name Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
266 Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...